Skip to main content

Advertisement

Table 1 Baseline characteristics of the study population

From: Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial

  Continuous infusion (n = 43) Bolus (n = 39)
Age (years) 80 ± 4 79 ± 5
Sex   
 Female 24 18
 Male 19 21
Baseline weight (kg) 72 ± 7 69.7 ± 10
Blood pressure (mmHg) 142/87 145/86
Heart rate (beats/minute) 102 ± 12 98 ± 16
Cardiac disease   
 Coronary artery disease 24 21
 Idiopathic cardiomyopathy 7 7
 Hypertrophic cardiomiopathy 4 6
 Valvular disease 8 5
Baseline creatinine (mg/dl) 1.62 ± 0.5 1.52 ± 0.4
BUN 100.60 ± 60 69.2 ± 31
eGFR (mL/min/1.73 m2)) 43.2 ± 7.6 45.7 ± 8.7
Serum sodium (mEq/L) 137.2 ± 5 138 ± 5
Serum potassium (mEq/L) 4.19 ± 0.4 4.26 ± 0.5
Left ventricular ejection fraction (%) 34.3 ± 10 35.8 ± 8
LV internal diastolic diameter (mm) 68 ± 8 66 ± 9
LV internal systolic diameter (mm) 48 ± 10 45 ± 8
Estimated Pulmonary Artery (PA) systolic pressure (mmHg) 50 ± 6 48 ± 5
Signs of congestion   
 Elevated jugular venous pressure 16 18
 Additive heart sound 11 13
 Peripheral edema 33 30
 Pulmonary rales 38 35
Coronary risk factors (%)   
 Diabetes mellitus 55.2 61.1
 Hypertension 89.4 87.9
 Dyslipidemia 72.4 75
 Previous Coronary artery disease (CAD) 46.2 49.4
Atrial fibrillation (%) 36.6 41.3
Baseline BNP (pg/mL) 1204 ± 693 1099 ± 571
Previous therapy   
 ACE-inhibitors 38 33
 β-Blockers 22 21
 Nitrates 25 26
 Diuretics 39 35
 Angiotensin receptor blockers 5 7
 Digoxin 13 11
 Aldosterone antagonist 15 12
  1. Results are presented as mean ± SD or number, unless stated otherwise. BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; LV, Left Ventricular; BNP, B-type natriuretic peptide.